Skip to main content
. 2022 Jul 25;8:17. doi: 10.1186/s41016-022-00283-3

Table 3.

Meta-analysis results

Outcomes Overall effect Heterogeneity
Effect estimate 95% CI p-Value I2(%) p-Value
Efficacy mRS(0-2) 1.327 1.093-1.612 <0.05 38.8 0.091
Rebleeding rate 1.410 1.092-1.822 <0.05 10.6 0.337
Mortality 1.116 1.054-1.180 <0.05 36.9 0.047
Complete occlusion 0.375 0.308-0.456 <0.05 0.0 0.424
Complications Vasospasm 0.787 0.649-0.954 <0.05 41.1 0.060
Hydrocephaly 1.143 1.043-1.252 <0.05 30.7 0.173
Cerebral infarction 0.669 0.596-0.751 <0.05 18.9 0.238
Neuro deficits 0.720 0.582-0.892 <0.05 15.6 0.315

Note: mRS = Modified Rankin Scale; GOS = Glasgow Outcome Scale